(ALLE) Allegion - Overview
Exchange: NYSE •
Country: Ireland •
Currency: USD •
Type: Common Stock •
ISIN: IE00BFRT3W74
Stock: Locks, Access Control, Door Hardware, Exit Devices, Software
Total Rating 63
Risk 86
Buy Signal 0.69
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.39% |
| Yield on Cost 5y | 1.87% |
| Yield CAGR 5y | 9.10% |
| Payout Consistency | 100.0% |
| Payout Ratio | 25.3% |
| Risk 5d forecast | |
|---|---|
| Volatility | 21.1% |
| Relative Tail Risk | -5.55% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.20 |
| Alpha | 24.47 |
| Character TTM | |
|---|---|
| Beta | 0.641 |
| Beta Downside | 0.527 |
| Drawdowns 3y | |
|---|---|
| Max DD | 23.72% |
| CAGR/Max DD | 0.62 |
Description: ALLE Allegion January 03, 2026
Allegion plc (NYSE:ALLE) designs, manufactures, and services a broad portfolio of security products-including mechanical locks, electronic access-control systems, door hardware, and related software-under brands such as Schlage, Interflex, and Von Duprin. Its solutions serve commercial, institutional, and residential customers across sectors like education, healthcare, government, hospitality, and retail, and are distributed through specialty distributors, e-commerce platforms, and DIY home-improvement retailers.
Key operating metrics (FY 2024) show revenue of $3.6 billion, a 4.2% year-over-year increase, and an adjusted EBITDA margin of roughly 18%, reflecting strong pricing power in a market where global security-equipment spending is projected to grow 6% CAGR through 2028. The business is sensitive to construction-activity cycles and corporate-capex budgets, while its recurring SaaS-based access-control offerings contribute higher-margin, subscription-type revenue that mitigates cyclicality.
For a deeper quantitative assessment, consider exploring Allegion’s valuation and risk profile on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 9.5
| Net Income: 640.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.13 > 0.02 and ΔFCF/TA 1.72 > 1.0 |
| NWC/Revenue: 15.35% < 20% (prev 20.70%; Δ -5.35% < -1%) |
| CFO/TA 0.15 > 3% & CFO 787.7m > Net Income 640.4m |
| Net Debt (1.96b) to EBITDA (976.2m): 2.00 < 3 |
| Current Ratio: 1.77 > 1.5 & < 3 |
| Outstanding Shares: last quarter (86.5m) vs 12m ago -1.26% < -2% |
| Gross Margin: 45.12% > 18% (prev 0.44%; Δ 4468 % > 0.5%) |
| Asset Turnover: 78.04% > 50% (prev 74.87%; Δ 3.17% > 0%) |
| Interest Coverage Ratio: 8.39 > 6 (EBITDA TTM 976.2m / Interest Expense TTM 101.1m) |
Altman Z'' 3.83
| A: 0.12 (Total Current Assets 1.40b - Total Current Liabilities 792.6m) / Total Assets 5.23b |
| B: 0.41 (Retained Earnings 2.13b / Total Assets 5.23b) |
| C: 0.17 (EBIT TTM 847.9m / Avg Total Assets 5.10b) |
| D: 0.59 (Book Value of Equity 1.92b / Total Liabilities 3.28b) |
| Altman-Z'' Score: 3.83 = AA |
Beneish M -2.90
| DSRI: 1.02 (Receivables 501.0m/458.8m, Revenue 3.98b/3.72b) |
| GMI: 0.97 (GM 45.12% / 43.96%) |
| AQI: 1.19 (AQ_t 0.65 / AQ_t-1 0.55) |
| SGI: 1.07 (Revenue 3.98b / 3.72b) |
| TATA: -0.03 (NI 640.4m - CFO 787.7m) / TA 5.23b) |
| Beneish M-Score: -2.90 (Cap -4..+1) = A |
What is the price of ALLE shares?
As of February 05, 2026, the stock is trading at USD 173.04 with a total of 911,297 shares traded.
Over the past week, the price has changed by +4.94%, over one month by +6.89%, over three months by +4.85% and over the past year by +36.55%.
Over the past week, the price has changed by +4.94%, over one month by +6.89%, over three months by +4.85% and over the past year by +36.55%.
Is ALLE a buy, sell or hold?
Allegion has received a consensus analysts rating of 3.25.
Therefor, it is recommend to hold ALLE.
- StrongBuy: 1
- Buy: 3
- Hold: 6
- Sell: 2
- StrongSell: 0
What are the forecasts/targets for the ALLE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 181.3 | 4.8% |
| Analysts Target Price | 181.3 | 4.8% |
| ValueRay Target Price | 195.9 | 13.2% |
ALLE Fundamental Data Overview January 31, 2026
P/E Trailing = 22.1931
P/E Forward = 18.7617
P/S = 3.5407
P/B = 7.2685
P/EG = 1.8567
Revenue TTM = 3.98b USD
EBIT TTM = 847.9m USD
EBITDA TTM = 976.2m USD
Long Term Debt = 2.06b USD (from longTermDebt, last quarter)
Short Term Debt = 69.4m USD (from shortTermDebt, last quarter)
Debt = 2.26b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.96b USD (from netDebt column, last quarter)
Enterprise Value = 16.05b USD (14.09b + Debt 2.26b - CCE 302.7m)
Interest Coverage Ratio = 8.39 (Ebit TTM 847.9m / Interest Expense TTM 101.1m)
EV/FCF = 22.85x (Enterprise Value 16.05b / FCF TTM 702.4m)
FCF Yield = 4.38% (FCF TTM 702.4m / Enterprise Value 16.05b)
FCF Margin = 17.65% (FCF TTM 702.4m / Revenue TTM 3.98b)
Net Margin = 16.09% (Net Income TTM 640.4m / Revenue TTM 3.98b)
Gross Margin = 45.12% ((Revenue TTM 3.98b - Cost of Revenue TTM 2.18b) / Revenue TTM)
Gross Margin QoQ = 45.77% (prev 45.65%)
Tobins Q-Ratio = 3.07 (Enterprise Value 16.05b / Total Assets 5.23b)
Interest Expense / Debt = 1.18% (Interest Expense 26.6m / Debt 2.26b)
Taxrate = 9.81% (20.5m / 208.9m)
NOPAT = 764.7m (EBIT 847.9m * (1 - 9.81%))
Current Ratio = 1.77 (Total Current Assets 1.40b / Total Current Liabilities 792.6m)
Debt / Equity = 1.16 (Debt 2.26b / totalStockholderEquity, last quarter 1.95b)
Debt / EBITDA = 2.00 (Net Debt 1.96b / EBITDA 976.2m)
Debt / FCF = 2.79 (Net Debt 1.96b / FCF TTM 702.4m)
Total Stockholder Equity = 1.71b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.56% (Net Income 640.4m / Total Assets 5.23b)
RoE = 37.45% (Net Income TTM 640.4m / Total Stockholder Equity 1.71b)
RoCE = 22.49% (EBIT 847.9m / Capital Employed (Equity 1.71b + L.T.Debt 2.06b))
RoIC = 20.40% (NOPAT 764.7m / Invested Capital 3.75b)
WACC = 7.28% (E(14.09b)/V(16.35b) * Re(8.28%) + D(2.26b)/V(16.35b) * Rd(1.18%) * (1-Tc(0.10)))
Discount Rate = 8.28% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.97%
[DCF Debug] Terminal Value 83.34% ; FCFF base≈654.8m ; Y1≈788.3m ; Y5≈1.27b
Fair Price DCF = 269.8 (EV 25.17b - Net Debt 1.96b = Equity 23.21b / Shares 86.0m; r=7.28% [WACC]; 5y FCF grow 21.79% → 2.90% )
EPS Correlation: -5.70 | EPS CAGR: -40.97% | SUE: -4.0 | # QB: 0
Revenue Correlation: 87.14 | Revenue CAGR: 11.60% | SUE: 1.97 | # QB: 2
EPS next Quarter (2026-03-31): EPS=1.97 | Chg30d=-0.043 | Revisions Net=-3 | Analysts=6
EPS next Year (2026-12-31): EPS=8.86 | Chg30d=-0.036 | Revisions Net=-1 | Growth EPS=+8.2% | Growth Revenue=+6.3%
P/E Forward = 18.7617
P/S = 3.5407
P/B = 7.2685
P/EG = 1.8567
Revenue TTM = 3.98b USD
EBIT TTM = 847.9m USD
EBITDA TTM = 976.2m USD
Long Term Debt = 2.06b USD (from longTermDebt, last quarter)
Short Term Debt = 69.4m USD (from shortTermDebt, last quarter)
Debt = 2.26b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.96b USD (from netDebt column, last quarter)
Enterprise Value = 16.05b USD (14.09b + Debt 2.26b - CCE 302.7m)
Interest Coverage Ratio = 8.39 (Ebit TTM 847.9m / Interest Expense TTM 101.1m)
EV/FCF = 22.85x (Enterprise Value 16.05b / FCF TTM 702.4m)
FCF Yield = 4.38% (FCF TTM 702.4m / Enterprise Value 16.05b)
FCF Margin = 17.65% (FCF TTM 702.4m / Revenue TTM 3.98b)
Net Margin = 16.09% (Net Income TTM 640.4m / Revenue TTM 3.98b)
Gross Margin = 45.12% ((Revenue TTM 3.98b - Cost of Revenue TTM 2.18b) / Revenue TTM)
Gross Margin QoQ = 45.77% (prev 45.65%)
Tobins Q-Ratio = 3.07 (Enterprise Value 16.05b / Total Assets 5.23b)
Interest Expense / Debt = 1.18% (Interest Expense 26.6m / Debt 2.26b)
Taxrate = 9.81% (20.5m / 208.9m)
NOPAT = 764.7m (EBIT 847.9m * (1 - 9.81%))
Current Ratio = 1.77 (Total Current Assets 1.40b / Total Current Liabilities 792.6m)
Debt / Equity = 1.16 (Debt 2.26b / totalStockholderEquity, last quarter 1.95b)
Debt / EBITDA = 2.00 (Net Debt 1.96b / EBITDA 976.2m)
Debt / FCF = 2.79 (Net Debt 1.96b / FCF TTM 702.4m)
Total Stockholder Equity = 1.71b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.56% (Net Income 640.4m / Total Assets 5.23b)
RoE = 37.45% (Net Income TTM 640.4m / Total Stockholder Equity 1.71b)
RoCE = 22.49% (EBIT 847.9m / Capital Employed (Equity 1.71b + L.T.Debt 2.06b))
RoIC = 20.40% (NOPAT 764.7m / Invested Capital 3.75b)
WACC = 7.28% (E(14.09b)/V(16.35b) * Re(8.28%) + D(2.26b)/V(16.35b) * Rd(1.18%) * (1-Tc(0.10)))
Discount Rate = 8.28% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.97%
[DCF Debug] Terminal Value 83.34% ; FCFF base≈654.8m ; Y1≈788.3m ; Y5≈1.27b
Fair Price DCF = 269.8 (EV 25.17b - Net Debt 1.96b = Equity 23.21b / Shares 86.0m; r=7.28% [WACC]; 5y FCF grow 21.79% → 2.90% )
EPS Correlation: -5.70 | EPS CAGR: -40.97% | SUE: -4.0 | # QB: 0
Revenue Correlation: 87.14 | Revenue CAGR: 11.60% | SUE: 1.97 | # QB: 2
EPS next Quarter (2026-03-31): EPS=1.97 | Chg30d=-0.043 | Revisions Net=-3 | Analysts=6
EPS next Year (2026-12-31): EPS=8.86 | Chg30d=-0.036 | Revisions Net=-1 | Growth EPS=+8.2% | Growth Revenue=+6.3%